ANVISA registration 80146502416Active

BILIRUBIN

Name: BILIRUBIN — ANVISA registration 80146502416
Creator: ABBOTT GMBH
Keywords: BILIRUBIN, BILIRRUBINA, Alinity c Direct Bilirubin Reagent Kit, 80146502416, Risk Class II, ANVISA registration

ANVISA Registration Number: 80146502416ABBOTT LABORATORIOS DO BRASIL LTDAABBOTT GMBHRisk Class II

Verified

Device names

Technical name: BILIRUBIN
Commercial name: Alinity c Direct Bilirubin Reagent Kit
Risk class: Class II

Registration details

Registration Number: 80146502416
Process Number: 25351237209202534
CNPJ: 56998701000116

Company information

Registration Holder: ABBOTT LABORATORIOS DO BRASIL LTDA
Manufacturer: ABBOTT GMBH
Manufacturing Country: Germany

Dates and status

Publication Date: Jan 12, 2026
Validity: VIGENTE
Last Updated: 08/18/2026 19:00:00

About this record

Access comprehensive regulatory information for BILIRUBIN in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 80146502416 and manufactured by ABBOTT GMBH. The registration is held by ABBOTT LABORATORIOS DO BRASIL LTDA with validity until currently active (VIGENTE).

This page shows the facts attached to this official registry row. Exact-name links return deterministic registry matches; open-ended comparison and market analysis are handed to AI Search with this record's context, without asserting that similar names represent the same entity.